Clinical Experience With 75-mg Dose of Erlotinib for Mutated Metastatic EGFR Non-small Cell Lung Cancer
Author:
Aren Osvaldo,Samtani Suraj,Frelinghuysen Micahel,Burotto Mauricio
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine